🚀 RECENT AI SUCCESS

Our AI successfully predicted the gap for $HLT and executed a BUY strategy, securing a +1.48% net profit.

UPGRADE TO SEE LIVE SIGNALS

$ONCIN.OL

Oncoinvent ASA

NorwayNORWAY
FREE PREVIEW
📅 Next Earnings: Aug 27, 2026 🌙 Close🌐 Website🏛️ Euronext Oslo📁 Health Technology🏭 Pharmaceuticals Major
AVG HISTORICAL GAP-6.08%
MAX GAP RECORD-6.08%
PREMIUM
AI ACCURACY RATE
92.4%
Unlock AI Insights 🔓

LAST 10 EARNINGS GAPS (%)

VOLATILITY & BIAS PROFILE

AVG VOLATILITY6.1%
Bullish Gaps
Bearish Gaps
Neutral

Intelligence Brief

Oncoinvent ASA operates as a clinical-phase biotechnology company, which engages in the development of radiopharmaceutical treatment products for cancer therapy. Its focus product is Radspherin, which uses the alpha-emitting radionuclide radium-224 that targets residual micrometastases after surgery in the abdominal cavity. The company was founded by Roy H. Larsen, Øyvind Bruland, Dr. Tina Bønsdorff, and Dr. Thora Jonasdottir on December… Read full dossier

CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL
AI MARKET SCANNING